This study focuses on identifying biomarkers, but certain analyses might include genetic testing. The research team will explain the process and obtain your consent if genetic testing is involved.
Advancing Early Detection of Lung Cancer
About the Lung Cancer Diagnosis Biorepository Clinical Trials
Hightower Clinical partnered with leading pharmaceutical organizations to conduct Lung Cancer Diagnosis Biorepository Clinical Trials in Oklahoma City, OK. This prospective, multi-center, observational study focused on screening blood for potential biomarkers to enable early detection of lung cancer.
The trial enrolled participants aged 50 and older with a smoking history of at least 20 years. By collecting blood samples from high-risk individuals, the study aimed to validate a blood-based test for the early detection of lung cancer, paving the way for more effective diagnostic tools.
Current Status
Not Recruiting
Study Count
01
Study Information
Lung Cancer Diagnosis
| Study Name | Protocol Number | Sponsor |
|---|---|---|
| Lung Cancer Diagnosis | FRNM-007 | Freenome |
Frequently Asked Questions
What happens to the blood samples after the study ends?
Blood samples are securely stored in the biorepository for future research purposes. They are anonymized to protect your privacy and used only for approved scientific investigations.
Will I receive any results from the blood tests performed during the study?
The study’s primary goal is research, so individual test results may not be shared with participants. However, any findings that are clinically relevant to your health will be communicated to you by the study team.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.